Argent BioPharma Ltd (ASX:RGT) Completes US$4.5 Million Capital Raise
Argent BioPharma Ltd (ASX:RGT) successfully raises US$4.5 million to advance its drug development pipeline.
The Hub of Australian Finance News
Argent BioPharma Ltd (ASX:RGT) successfully raises US$4.5 million to advance its drug development pipeline.
iCandy Interactive Limited (ASX:ICI) announces a temporary pause in trading due to compliance regulations pending further updates.
Australian Rare Earths Limited has secured a $5 million grant for the Koppamurra Project to support the clean energy sector.
Syrah Resources has secured a waiver on DFC loan defaults due to operational challenges at its Balama site in Mozambique.
Blackstone Minerals Limited (ASX:BSX) expands its portfolio to include copper-gold assets, enhancing growth strategies and joint ventures.
Russell Investment Management Limited announces a final distribution of 21.8202 cents per unit for the Australian Select Corporate Bond ETF (ASX:RCB).
Aguia Resources Limited (ASX:AGR) announces significant advancements at the Santa Barbara Gold Project, including processing and exploration plans.
BrainChip Holdings secures an additional AUD $20M in its amendment of the Put Option Agreement with LDA Group to support product development.
Adveritas Limited announces substantial progress and upcoming growth strategies in the sports betting and eCommerce sectors.
Gladiator Resources confirms significant high-grade extensions at the Mkuju Uranium Project, enhancing its growth outlook.